Revolution Medicines, Inc.RVMDNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | -23.17% |
| Q2 2025 | -16.11% |
| Q1 2025 | -9.69% |
| Q4 2024 | -24.49% |
| Q3 2024 | -17.30% |
| Q2 2024 | -14.85% |
| Q1 2024 | 28.19% |
| Q4 2023 | -48.97% |
| Q3 2023 | -10.31% |
| Q2 2023 | -44.35% |
| Q1 2023 | -20.51% |
| Q4 2022 | 22.94% |
| Q3 2022 | -19.78% |
| Q2 2022 | -6.20% |
| Q1 2022 | -9.44% |
| Q4 2021 | 0.50% |
| Q3 2021 | -19.51% |
| Q2 2021 | -19.16% |
| Q1 2021 | -8.69% |
| Q4 2020 | -25.65% |
| Q3 2020 | -0.02% |
| Q2 2020 | -39.43% |
| Q1 2020 | -33.73% |
| Q4 2019 | -13.87% |
| Q3 2019 | -26.67% |
| Q2 2019 | 0.12% |
| Q1 2019 | 10.65% |
| Q4 2018 | 0.00% |